UA30011A - The method of prophylaxis of acute stress gastrointestinal tract lesions after the cavitary surgery - Google Patents

The method of prophylaxis of acute stress gastrointestinal tract lesions after the cavitary surgery

Info

Publication number
UA30011A
UA30011A UA97125844A UA97125844A UA30011A UA 30011 A UA30011 A UA 30011A UA 97125844 A UA97125844 A UA 97125844A UA 97125844 A UA97125844 A UA 97125844A UA 30011 A UA30011 A UA 30011A
Authority
UA
Ukraine
Prior art keywords
cavitary
prophylaxis
gastrointestinal tract
surgery
acute stress
Prior art date
Application number
UA97125844A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Олександр Якович Яремчук
Александр Яковлевич Яремчук
Олексій Сергійович Зотов
Алексей Сергеевич Зотов
Стелла Борисівна Французова
Стелла Борисовна Французова
Original Assignee
Національний Медичний Університет Ім. Акад. О.О. Богомольця.
Национальный Медицинский Университет Им. А.А.Богомольца
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Національний Медичний Університет Ім. Акад. О.О. Богомольця., Национальный Медицинский Университет Им. А.А.Богомольца filed Critical Національний Медичний Університет Ім. Акад. О.О. Богомольця.
Priority to UA97125844A priority Critical patent/UA30011A/en
Publication of UA30011A publication Critical patent/UA30011A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The Method of prophylaxis of acute stress gastrointestinal tract lesions after the cavitary surgery includes the introduction of medicinal preparations. In preoperational period within 7-10 day there are 5 ml of 5 % myldronate solution introduced, and in the course of the operation - 24 ml of 5 % Isoptin solution are administered.
UA97125844A 1997-12-05 1997-12-05 The method of prophylaxis of acute stress gastrointestinal tract lesions after the cavitary surgery UA30011A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA97125844A UA30011A (en) 1997-12-05 1997-12-05 The method of prophylaxis of acute stress gastrointestinal tract lesions after the cavitary surgery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA97125844A UA30011A (en) 1997-12-05 1997-12-05 The method of prophylaxis of acute stress gastrointestinal tract lesions after the cavitary surgery

Publications (1)

Publication Number Publication Date
UA30011A true UA30011A (en) 2000-11-15

Family

ID=74195774

Family Applications (1)

Application Number Title Priority Date Filing Date
UA97125844A UA30011A (en) 1997-12-05 1997-12-05 The method of prophylaxis of acute stress gastrointestinal tract lesions after the cavitary surgery

Country Status (1)

Country Link
UA (1) UA30011A (en)

Similar Documents

Publication Publication Date Title
EG20401A (en) Process for preparing of veterinary composition for the treatment of gastric acid related deseases in animals
MY115351A (en) Pharmaceutical formulations
CY1105707T1 (en) COMBINATIONS OF FORMOTEROL AND A TRIOTROP SALT
AU6271401A (en) Drug administering system and administering method
HU9602937D0 (en) Compositions comprising dna damaging agents and p53
AU1227899A (en) Osmotic medicament releasing system
AU6628496A (en) Polyether block copolymer micellar compositions for targeting biological agents
EP1820862A3 (en) Medical preparations for the treatment of alpha-galactosidase a deficiency
AU3581697A (en) Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
HUP0104803A3 (en) Process and system for the administration of medicine through the skin
WO1998035658A3 (en) The use of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone
PL329940A1 (en) Compositions for once-a-day administration for use in treating diseases involving mediator effect of cyclooxygenase-2
AU9018898A (en) Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
AU752280C (en) Conjugate of therapeutic agent for joint disease and hyaluronic acid.
CA2294921A1 (en) Levobupivacaine and its use
HUP0003840A2 (en) Controlled released medical formulation
GB9808840D0 (en) Treatment of depression and pharmaceutical preparations therefor
IL125913A0 (en) Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and medicament for the treatment of cardio-vascular diseases
HUP9903353A3 (en) 7alpha-(methyl-amino-pentyl)-estratrienes, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl) -estratrienes and use thereof for production of drugs
EP0744176A3 (en) Methods for inhibiting bone loss
NO963634D0 (en) Anti-cough preparation containing an anti-cough agent and benzydamine
UA30011A (en) The method of prophylaxis of acute stress gastrointestinal tract lesions after the cavitary surgery
GB2333042B (en) Colonic delivery of weak acid drugs
AU1200488A (en) Protein c inhibitor (pci) as pharmaceutical and in vitro diagnostic aid, a process for the preparation of a pharmaceutical or diagnostic aid of this type, and an agent containing pci
AU3439897A (en) Pharmaceutical formulations containing colostrum and their use